Lonaprisan

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameLonaprisan
Drug Alias Name罗那利桑lonaprisanlonaprisanum洛那立生ZK-230211 +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProgesterone receptor antagonists
TargetsProgesterone receptor
Therapy Area/IndicationsMetastatic breast cancer
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenPolandItaly +[10] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBayer AG
Active IndicationsN/A
Inactive IndicationsMetastatic breast cancer

Other Information

ATC CodeN/A
Related LinksKEGG